C83.37
Diffuse large B-cell lymphoma, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse large B-cell lymphoma (DLBCL) of the spleen is a type of non-Hodgkin lymphoma characterized by the rapid growth of malignant B lymphocytes within the spleen. As one of the most common forms of non-Hodgkin lymphoma, it can affect individuals of any age but is more prevalent among older adults. The disease involves abnormal immune cells multiplying uncontrollably, leading to enlargement of the spleen and potentially affecting other parts of the body. Accurate diagnosis and strategic treatment are crucial for managing this aggressive lymphoma.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting B lymphocytes Immune system deficiencies Exposure to certain chemicals or radiation History of other lymphoid cancers Infections such as Epstein-Barr virus (EBV) or human immunodeficiency virus (HIV) Autoimmune disorders
Key Symptoms: Enlarged spleen, leading to a feeling of fullness or discomfort in the upper left abdomen Unexplained weight loss Fever that persists over time Night sweats Fatigue and weakness Frequent infections Swelling of lymph nodes outside the spleen
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess spleen size and lymph node involvement Blood tests to check for abnormal blood cell counts and signs of infection or organ dysfunction Imaging studies such as ultrasound, CT scans, or PET scans to visualize spleen enlargement and detect spread Biopsy of the spleen or affected tissue to confirm malignant B-cell presence Bone marrow biopsy to determine if the disease has spread to the marrow
Treatment Protocols: Chemotherapy regimens like R-CHOP, which involve multiple anticancer drugs administered over several cycles Radiation therapy targeted at the spleen or affected regions to reduce tumor size Immunotherapy, such as monoclonal antibodies targeting specific cancer markers Stem cell or bone marrow transplantation in cases of refractory or relapsed disease Supportive care to manage symptoms and side effects, including transfusions and infection prophylaxis
Clinical Advice & FAQs
Billing Guidance
Is C83.37 a billable ICD-10 code?
Yes, C83.37 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.37?
Clinical documentation must specify the nature of Diffuse large B-cell lymphoma, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference